Genetic, metabolic and clinical characteristics of maturity onset diabetics of the young

European Journal of Endocrinology

Volumn 138, Issue 3, 1998, Pages 233-239

  Velho, Gilberto ^a   Froguel, Philippe ^b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE; GLYCOGEN; INSULIN; INSULIN PROMOTER FACTOR 1; NUCLEAR FACTOR; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CHROMOSOME 12Q; CHROMOSOME 20Q; CHROMOSOME 7P; DIABETIC RETINOPATHY; GENE MUTATION; GENETIC SUSCEPTIBILITY; GLUCONEOGENESIS; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

ADOLESCENT; ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CHILD; DIABETES MELLITUS, TYPE 2; DNA-BINDING PROTEINS; FEMALE; GLUCOKINASE; GLYCOGEN; HEPATOCYTE NUCLEAR FACTOR 1; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HEPATOCYTE NUCLEAR FACTOR 4; HOMEODOMAIN PROTEINS; HUMANS; LIVER; MALE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PREVALENCE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0031965862     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1380233     Document Type: Review

References (61)

1. Velho G & Froguel P. The genetic determinants of NIDDM: strategies and recent results. Diabetes and Metabolism 1997 23 7-17.
2. Steiner DF, Tager HS, Chan SJ, Nanjo K, Sanke T & Rubenstein AH. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 1990 13 600-609.
3. Van den Ouweland JMW, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, De Vijlder MF, Struyvenberg PAA et al. Mutation in mitochondrial tNRA Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes and deafness. Nature Genetics 1992 1 368-371.
4. Taylor SI. Molecular mechanisms of insulin resistance: lessons from patients with mutations in the insulin-receptor gene. Diabetes 1992 41 1473-1490.
5. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. New England Journal of Medicine 1993 328 697-702.
6. Froguel P, Vaxillaire M & Velho G. Genetic and metabolic heterogeneity of maturity onset diabetes of the young. Diabetes Reviews 1997 5 123-130.
7. Bell GI, Xiang KS, Newman MV, Wu SH, Wright LG, Fajans SS et al. Gene for non insulin dependent diabetes mellitus (maturity onset diabetes of the young subtype) is linked to DNA polymorphism on chromosome 20q. Proceedings of the National Academy of Sciences of the USA 1991 88 1484-1488.
8. Yamagata K, Furuta H, Oda O, Kaisaki PJ, Menzel S, Cox NJ et al. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996 384 458-460.
9. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO et al. The glucokinase locus on chromosome 7p is closely linked to early onset non insulin dependent diabetes mellitus. Nature 1992 356 162-164.
10. Velho G, Blanché H, Vaxillaire M, Bellanné-Chantelot C, Pardini VC, Timsit J et al. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 1997 40 217-224.
11. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nature Genetics 1995 9 418-423.
12. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M et al. Mutations in the hepatocyte nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996 384 455-458.
13. Chèvre JC, Hani EH, Boutin P, Vionnet N, Vaxillaire M, Yamagata K et al. Mutation screening of the hepatocyte nuclear factor-1α and 4α genes in MODY families: suggestion of the existence of at least a fourth MODY gene. Diabetologia 1997 40 (Suppl 1) A157 (Abstract).
14. Fajans SS. Scope and heterogeneous nature of MODY. Diabetes Care 1990 13 49-64.
15. Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet 1995 345 648 (Letter).
16. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj VV et al. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY 3). Human Molecular Genetics 1997 6 583-586.
17. Frayling TM, Bulman MP, Ellard S, Appleton M, Dronsfleld MJ, Mackle ADR et al. Mutations in the hepatocyte nuclear factor-1 alpha gene are a common cause of maturity-onset diabetes of the young in the UK Diabetes 1997 46 720-725.
18. Matschinsky FM. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes 1996 45 223-241.
19. Blanché H, Carel J, Czernichow P, Froguel P, Guazzarotti L, Passa P et al. Criblage moléculaire de la glucokinase: 37 nouvelles mutations. Diabete et Metabolisme 1997 23 (Suppl 1) 29 (Abstract).
20. Gidh-Jain M, Takeda J, Xu LZ, Lange AJ, Vionnet N, Stoffel M et al. Glucokinase mutations associated with non insulin dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships. Proceedings of the National Academy of Sciences of the USA 1993 90 1932-1936.
21. Sturis J, Kurland IJ, Byrne MM, Mosekilde E, Froguel P, Pilkis SJ et al. Compensation in pancreatic beta-cell function in subjects with glucokinase mutations. Diabetes 1994 43 718-723.
22. Velho G, Froguel P, Clément K, Pueyo ME, Rakotoambinina B, Zouali H et al. Primary pancreatic beta-cell secretory defect caused by mutations in the glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 1992 340 444-448.
23. Byrne MM, Sturis J, Clément K, Vionnet N, Pueyo ME, Stoffel M et al. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. Journal of Clinical Investigation 1994 93 1120-1130.
24. Pueyo ME, Clement K, Vaxillaire M, Passa P, Froguel P, Robert JJ et al. Arginine-induced insulin release in glucokinase-deficient subjects. Diabetes Care 1994 17 1015-1021.
25. Velho G, Petersen KF, Perseghin G, Hwang J-H, Rothman DL, Pueyo ME et al. Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. Journal of Clinical Investigation 1996 98 1755-1761.
26. Moore MC, Cherrington AD, Cline G, Pagliassotti MJ, Jones EM, Neal DW et al. Sources of carbon for hepatic glycogen synthesis in the conscious dog. Journal of Clinical Investigation 1991 88 578-587.
27. DeFronzo RA, Bonadonna RC & Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 1992 15 318-368.
28. Clément K, Pueyo ME, Vaxillaire M, Rakotoambinina B, Thuillier F, Passa P et al. Assessment of insulin sensitivity in glucokinase-deficient subjects. Diabetologia 1996 39 82-90.
29. Tappy L, Dussoix P, Iynedjian P, Henry S, Schneiter P, Zahnd G et al. Abnormal regulation of hepatic glucose output in maturity onset diabetes of the young caused by a specific mutation of the glucokinase gene. Diabetes 1997 46 204-208.
30. Efrat S, Leiser M, Wu YJ, Fusco-DeMane D, Emran OA, Surana M et al. Rybozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion. Proceedings of the National Academy of Sciences of the USA 1994 91 2051-2055.
31. Bali D, Svetlanov A, Lee HW, Fusco-DeMane D, Leiser M, Li B et al. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. Journal of Biological Chemistry 1995 270 21464-21467.
32. Grupe A, Hultgren B, Ryan A, Ma YH, Bauer M & Stewart TA. Transgenic knockouts reveal a critical requirement for pancreatic beta cell glucokinase in maintaining glucose homeostasis. Cell 1995 83 69-78.
33. Velho G, Vaxillaire M, Boccio V, Charpentier G & Froguel P. Diabetes complications in NIDDM kindreds linked to the MODY-3 locus on chromosome 12q. Diabetes Care 1996 19 915-919.
34. Tronche F & Yaniv M. HNF1, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 1992 14 579-587.
35. Boutin P, Chèvre JC, Gomis R, Pardini VC, Guillausseau PJ, Velho G et al. An automated fluorescent SSCP technique for screening for mutations the hepatocyte nuclear factor 1 alpha gene (MODY3). Diabetes 1997 46 2108-2109.
36. Kaisaki PJ, Menzel S, Lindner T, Oda N, Rjasanowski I, Sahm J et al. Mutations in the hepatocyte nuclear factor-1 alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4. Diabetes 1997 46 528-535.
37. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Moller AM, Rasmussen SK et al. Novel MODY3 mutations in the hepatocyte nuclear factor-1 alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 1997 46 726-730.
38. Glucksmann MA, Lehto M, Tayber O, Scotti S, Berkemeier L, Pulido JC et al. Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes 1997 46 1081-1086.
39. Velho G, Pueyo ME, Vaxillaire M, Clément K, Froguel P & Robert J-J. Assessment of insulin secretion and sensitivity in carriers of the diabetes susceptibility haplotype at the MODY-3 locus. Diabetes 1996 45 (Suppl 2) 297A (Abstract).
40. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ et al. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes mellitus susceptibility gene MODY on chromosome 12. Diabetes 1996 45 1503-1510.
41. Fajans SS, Bell GI, Bowden DW, Halter JB & Polonsky KS. Maturity-onset diabetes of the young. Life Sciences 1994 55 413-422.
42. Herman WH, Fajans SS, Ortiz FJ, Smith MJ, Sturis J, Bell GI et al. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 1994 43 40-46.
43. Byrne MM, Sturis J, Fajans SS, Ortiz FJ, Stoltz A, Stoffel M et al. Altered insulin secretory responses to glucose in subjects with a mutation in the MODY1 gene on chromosome 20. Diabetes 1995 44 699-704.
44. Bulman MP, Dronsfield MJ, Frayling T, Appleton M, Bain SC, Ellard S et al. A missense mutation in the hepatocyte nuclear factor 4 alpha gene in a UK pedigree with maturity-onset diabetes of the young. Diabetologia 1997 40 859-862.
45. Yki-Jarvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 1995 38 1378-1388.
46. Permutt MA, Chiu KC & Tanizawa Y. Glucokinase and NIDDM: a candidate gene that paid off. Diabetes 1992 41 1367-1372.
47. Zouali H, Vaxillaire M, Lesage S, Sun F, Velho G, Vionnet N et al. Linkage analysis and molecular scanning of the glucokinase gene in NIDDM families. Diabetes 1993 42 1238-1245.
48. Shelton KD, Franklin AJ, Khoor A, Beechem J & Magnuson MA. Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells. Molecular and Cellular Biology 1992 12 4578-4589.
49. Stone LM, Kahn SE, Fujimoto WY, Deeb SS & Porte D Jr. A variant at position -30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese-American men. Diabetes 1996 45 422-428.
50. Lesage S, Hani EH, Philippi A, Vaxillaire M, Hager J, Passa P et al. Linkage analyses of the MODY3 locus on chromosome 12q with late-onset NIDDM. Diabetes 1995 44 1243-1247.
51. Bowden DW, Sale M, Howard TD, Qadri A, Spray BJ, Rothschild CB et al. Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy. Diabetes 1997 46 882-886.
52. Mahtani MM, Widén E, Lehto M, Thomas J, McCarthy M, Brayer J et al. Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nature Genetics 1996 14 90-94.
53. Urhammer SA, Rasmussen SK, Kaisaki PJ, Oda N, Yamagata K, Moller AM et al. Genetic variation in the hepatocyte nuclear factor-1 alpha gene in Danish Caucasians with late-onset NIDDM. Diabetologia 1997 40 473-475.
54. Urhammer SA, Fridberg M, Hansen T, Rasmussen SK, Moller AM, Clausen JO et al. A prevalent amino acid polymorphism at codon 98 in the hepatocyte nuclear factor-1 alpha gene is associated with reduced serum C-peptide and insulin responses to an oral glucose challenge. Diabetes 1997 46 912-916.
55. Vaxillaire M, Butel MO, Zouali H, Sun F, Lesage S, Clément K et al. Linkage studies give evidence for genetic heterogeneity in type 2 diabetes mellitus. Diabetologia 1992 35 A62 (Abstract).
56. Baroni MG, Alcolado JC, Needham EWA, Pozzilli P, Stocks J & Galton DJ. Sib-pair analysis of adenosine deaminase locus in NIDDM. Diabetes 1992 41 1640-1643.
57. Hani EH, Suaud L, Boutin P, Chèvre JC, Durand E, Philippi A et al. A missense mutation in the Hepatocyte Nuclear Factor 4-Alpha, resulting in a reduced transactivational activity, in human late-onset non insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1998 (In Press).
58. Ohlsson H, Karlsson K & Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO Journal 1993 12 4251-4259.
59. Jonsson J, Carisson L, Edlund T & Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994 371 606-609.
60. Stoffers DA, Ferrer J, Clarke WL & Habener JF. Early-onset type 2 diabetes mellitus (MODY4) linked to IPF1. Nature Genetics 1997 17 138-139.
61. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL & Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nature Genetics 1997 15 106-110.